Cambridge Healthtech Institute’s 2nd Annual

Immuno-Oncology Biomarkers 1: Quantitative Immune Profiling and Immune Monitoring

August 27-28, 2018

Advances in immuno-oncology promise to revolutionize cancer treatment. However, many patients do not respond to immunotherapy. Immune profiling promises to identify biomarkers that predict response to immunotherapy and to help monitor its progress. Cambridge Healthtech Institute’s Second Annual Immuno-Oncology Biomarkers 1: Quantitative Immune Profiling and Immune Monitoring meeting will cover quantitative approaches to assess the state of the immune system, profile the tumor microenvironment and peripheral blood, determine tumor mutational burden and profile neoepitopes, and develop predictive and response biomarkers.

Coverage will include, but is not limited to:

  • Genetic profiling of tumor cells
  • Immune monitoring
  • Immunophenotyping
  • Advances in cytometry
  • Liquid biopsy for immuno-oncology
  • Immunosequencing
  • Immune cell infiltration profiling
  • Cytokine profiling
  • Neoepitope profiling
  • Mutational burden in tumors
  • Immunoscore assay
  • Tumor microenvironment profiling
  • Understanding mechanism of resistance

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286